Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas ; volume:15 ; number:1 ; day:19 ; month:5 ; year:2023 ; pages:1-33 ; date:12.2023
Clinical epigenetics ; 15, Heft 1 (19.5.2023), 1-33, 12.2023
- Urheber
-
Tang, Zijiao
Liu, Lu
Borlak, Jürgen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13148-023-01500-1
- URN
-
urn:nbn:de:101:1-2023090911465378017051
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tang, Zijiao
- Liu, Lu
- Borlak, Jürgen
- SpringerLink (Online service)
Ähnliche Objekte (12)
![Improved potency of decitabine in human colorectal cancer and colorectal liver metastasis cell lines, [Band].](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Improved potency of decitabine in human colorectal cancer and colorectal liver metastasis cell lines, [Band].
Correction to: Decitabine/Cedazuridine: First Approval
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
Epigenetic synergy between decitabine and platinum derivatives
Adenosine deaminase deficiency: a review
Earthquake fatalities and potency
Potency in soluble groups
Urogenital Abnormalities in Adenosine Deaminase Deficiency
Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation
Genomics and epidemiology for gastric adenocarcinomas
Finding the potency in planarians
Improved potency of decitabine in human colorectal cancer and colorectal liver metastasis cell lines, [Band].
Correction to: Decitabine/Cedazuridine: First Approval
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
Epigenetic synergy between decitabine and platinum derivatives
Adenosine deaminase deficiency: a review
Earthquake fatalities and potency
Potency in soluble groups
Urogenital Abnormalities in Adenosine Deaminase Deficiency
Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation
Genomics and epidemiology for gastric adenocarcinomas
Finding the potency in planarians
Improved potency of decitabine in human colorectal cancer and colorectal liver metastasis cell lines, [Band].
Correction to: Decitabine/Cedazuridine: First Approval
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
Epigenetic synergy between decitabine and platinum derivatives
Adenosine deaminase deficiency: a review
Earthquake fatalities and potency
Potency in soluble groups
Urogenital Abnormalities in Adenosine Deaminase Deficiency
Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation
Genomics and epidemiology for gastric adenocarcinomas